Feeds:
Posts
Comments

Search Results for 'Companion Diagnostics'

#TUBiol5227: Biomarkers & Biotargets: Genetic Testing and Bioethics

Posted in and Bioethics, Bio-Ethics, BioBanking, BioIT: BioInformatics, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, Biological Networks, Biomarkers & Medical Diagnostics, BioSimilars, Biotechnology, BioTechnology - Venture Creation, Cancer and Current Therapeutics, Cancer Genomics, Clinical Diagnostics, Clinical Genomics, Conference Coverage with Social Media, Ethics and Leadership, FDA, FDA Regulatory Affairs, Federal Budget Appropriations, Health Economics and Outcomes Research, Health Law Policy, Healthcare costs and reimbursement, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, interventional oncology, Next Generation Sequencing (NGS), Patent Law in Biotech, Patents, Patient Experience, Personal Health Applications: Tech Innovations serves HealhCare, Personalized and Precision Medicine & Genomic Research, Personalized Medicine Coalition, Precision Cancer Medicine, Regulated Clinical Trials: Design, Methods, Components and IRB related issues, Voices of Patients and Healthcare Providers, tagged , , , , , , , , , , , on September 28, 2021| Leave a Comment »

#TUBiol5227: Biomarkers & Biotargets: Genetic Testing and Bioethics Curator: Stephen J. Williams, Ph.D. The advent of direct to consumer (DTC) genetic testing and the resultant rapid increase in its popularity as well as companies offering such services has created some urgent and unique bioethical challenges surrounding this niche in the marketplace. At first, most DTC […]

Read Full Post »

NEW GENRE Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics – Series E, Volume 3

Posted in on July 22, 2022|

View on Amazon.com https://www.amazon.com/dp/B0BRNRB6KB since 1/3/2023   Audio y Texto NEW GENRE Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-e-patient-centered-medicine-precision-medicine/new-genre-volume-three-milestones-in-physiology-discoveries-in-medicine-and-genomics-series-e-volume-3%ef%bf%bc/   Original Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics On Amazon.com since 12/27/2015 http://www.amazon.com/dp/B019VH97LU   NEW GENRE Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics  https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-e-patient-centered-medicine-precision-medicine/new-genre-volume-three-milestones-in-physiology-discoveries-in-medicine-and-genomics-series-e-volume-3%ef%bf%bc/   This […]

Read Full Post »

NEW GENRE Volume One: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures – Series E, Volume 1

Posted in on July 22, 2022|

View on Amazon.com https://www.amazon.com/dp/B0BRGJZ8PG since 12/30/2022   Audio y Texto NEW GENRE Volume One: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-e-patient-centered-medicine-precision-medicine/new-genre-volume-one-the-voices-of-patients-hospitals-ceos-health-care-providers-caregivers-and-families-personal-experience-with-critical-care-and-invasive-medical-procedures-series-e-vo/   NEW GENRE Volume One: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with […]

Read Full Post »

Double Mutant PI3KA Found to Lead to Higher Oncogenic Signaling in Cancer Cells

Posted in Apoptosis, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Genomics, Cell Biology, Cell Biology, Signaling & Cell Circuits, Childhood cancer, Computational Biology/Systems and Bioinformatics, Genetics & Pharmaceutical, Genome Biology, Genomic Expression, Pharmaceutical Drug Discovery, tumor microenvironment, tagged , , , , , , , on September 24, 2020| Leave a Comment »

Double Mutant PI3KA Found to Lead to Higher Oncogenic Signaling in Cancer Cells Curator: Stephen J. Williams, PhD PIK3CA (Phosphatidylinsitol 4,5-bisphosphate (PIP2) 3-kinase catalytic subunit α) is one of the most frequently mutated oncogenes in various tumor types ([1] and http://www.sanger.ac.uk/genetics/CGP/cosmic). Oncogenic mutations leading to the overactivation of PIK3CA, especially in context in of inactivating […]

Read Full Post »

2019 Trends in Precision Medicine: A Perspective from Foundation Medicine

Posted in Personalized and Precision Medicine & Genomic Research on January 9, 2019| Leave a Comment »

2019 Trends in Precision Medicine: A Perspective from Foundation Medicine Reporter: Aviva Lev-Ari, PhD, RN   BIOPHARMA, DIAGNOSTICS Foundation Medicine appoints new CEO; exec provides forecasts for precision medicine in 2019 With the approval of Loxo’s Vitrakvi, pan-cancer drugs and an emphasis on real-world data are likely to become important trends trends this year. By ALARIC DEARMENT […]

Read Full Post »

Live Conference Coverage @Medcitynews Converge 2018 Philadelphia:Liquid Biopsy and Gene Testing vs Reimbursement Hurdles

Posted in Big Data & Analytics, BioBanking, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Screening, Circulating Tumor Cells (CTC), Clinical Genomics, Diagnostics and Lab Tests, FDA, Health Economics and Outcomes Research, Healthcare costs and reimbursement, KRAS Mutation, Liquid Biopsy Chip detects an array of metastatic cancer cell markers in blood, Liquid Biopsy: Circulating Tumor Cells in Urine and Blood, Patient-centered Medicine, Personalized and Precision Medicine & Genomic Research, Scientific & Biotech Conferences: Press Coverage, Uncategorized, tagged , , , , , , on July 12, 2018| Leave a Comment »

Live Conference Coverage @Medcitynews Converge 2018 Philadelphia:Liquid Biopsy and Gene Testing vs Reimbursement Hurdles Reporter: Stephen J. Williams, PhD   9:25- 10:15 Liquid Biopsy and Gene Testing vs. Reimbursement Hurdles Genetic testing, whether broad-scale or single gene-testing, is being ordered by an increasing number of oncologists, but in many cases, patients are left to pay […]

Read Full Post »

Medical Startups – Artificial Intelligence (AI) Startups in Healthcare

Posted in Academic Publishing, Advanced Computing Platform, Artificial Intelligence - General, Artificial Intelligence Applications in Health Care, Artificial Intelligence in CANCER, Artificial Intelligence in Health Care - Tools & Innovations, Big Data, BioIT: BioInformatics, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, Machine Learning, Natural Language Processing (NLP) on March 2, 2022| Leave a Comment »

  Medical Startups – Artificial Intelligence (AI) Startups in Healthcare Reporters: Stephen J. Williams, PhD and Aviva Lev-Ari, PhD, RN and Shraga Rottem, MD, DSc, The motivation for this post is two fold: First, we are presenting an application of AI, NLP, DL to our own medical text in the Genomics space. Here we present […]

Read Full Post »

LPBI Group is most HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019

Posted in on March 21, 2019|

LPBI Group is most HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019     UPDATED on 4/9/2023 @pharma_BI 26.6K Tweets UPDATED on 2/8/2021 Following @pharma_BI @Pharma_BI Follows you Official Twitter Account of Leaders […]

Read Full Post »

Live Coverage MedCity Converge 2018 Philadelphia: The David vs Goliaths, PrecisionMed Networks and Fireside Chat with Michael Pellini

Posted in Cancer Informatics, Conference Coverage with Social Media, Evidence-based decision-making, Health Economics and Outcomes Research, Health Law & Patient Safety, HealthCare IT, Uncategorized, tagged , , , , , , , , , on July 11, 2018| Leave a Comment »

Reporter: Stephen J. Williams, PhD 10:00-10:45 AM The Davids vs. the Cancer Goliath Part 1 Startups from diagnostics, biopharma, medtech, digital health and emerging tech will have 8 minutes to articulate their visions on how they aim to tame the beast. Start Time End Time Company 10:00 10:08 Belong.Life 10:09 10:17 Care+Wear 10:18 10:26 OncoPower […]

Read Full Post »

Connections First Level on LinkedIn: 500 CEOs, 200 Big Pharma Professionals, 7,000 in Total: LPBI Group Founder – Aviva Lev-Ari, PhD, RN

Posted in on April 5, 2019|

Connections First Level on LinkedIn: 500 CEOs, 200 Big Pharma Professionals, 7,000 in Total: LPBI Group’s Founder – Aviva Lev-Ari, PhD, RN Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 4/4/2022 Analytics for e-Reputation based on LinkedIn 1st Degree Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & Biotech […]

Read Full Post »

Next »